Clinically, the potential advantages for puerarin to treat endometriosis are as follows; first, puerarin is able to bind to ER-alpha and ER-beta [9], it can suppress P450arom activity as aromatase inhibitors in endometriosis treatment, and it may be applicable as an adjuvant to the current medical treatments. This evidence concerns the gene ESR2 and endometriosis.